Roger Song
Stock Analyst at Jefferies
(0.77)
# 3,756
Out of 4,761 analysts
41
Total ratings
27.27%
Success rate
-22.92%
Average return
Main Sectors:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.38 | +44.93% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $4.50 | +55.56% | 2 | Dec 9, 2024 | |
| REPL Replimune Group | Maintains: Buy | $16 → $19 | $13.98 | +35.91% | 1 | Dec 4, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $28 | $8.25 | +239.39% | 2 | Nov 21, 2024 | |
| ACRS Aclaris Therapeutics | Upgrades: Buy | $2 → $7 | $2.24 | +212.50% | 1 | Nov 19, 2024 | |
| IRON Disc Medicine | Initiates: Buy | $89 | $54.53 | +63.21% | 1 | Oct 23, 2024 | |
| NVAX Novavax | Maintains: Buy | $31 → $25 | $7.99 | +212.89% | 2 | Oct 16, 2024 | |
| NRIX Nurix Therapeutics | Initiates: Buy | $41 | $16.87 | +143.03% | 1 | Oct 11, 2024 | |
| ZBIO Zenas BioPharma | Initiates: Buy | $35 | $7.83 | +347.00% | 1 | Oct 8, 2024 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Buy | $40 | $20.02 | +99.80% | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.32 | +108.33% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $79.74 | +61.78% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $0.78 | +925.64% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $79.49 | +22.03% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $12.21 | +489.68% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $34.07 | +222.86% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $0.5 → $1 | $0.93 | +7.27% | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $6.43 | +444.32% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.87 | +933.41% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $675 | $2.79 | +24,093.55% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $4.19 | +90.93% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $0.29 | +1,256.39% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $1.77 | +1,086.44% | 1 | Sep 2, 2020 |
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.38
Upside: +44.93%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $4.50
Upside: +55.56%
Replimune Group
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $13.98
Upside: +35.91%
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $8.25
Upside: +239.39%
Aclaris Therapeutics
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $2.24
Upside: +212.50%
Disc Medicine
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $54.53
Upside: +63.21%
Novavax
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $7.99
Upside: +212.89%
Nurix Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $16.87
Upside: +143.03%
Zenas BioPharma
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $7.83
Upside: +347.00%
Kiniksa Pharmaceuticals International,
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $20.02
Upside: +99.80%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $4.32
Upside: +108.33%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $79.74
Upside: +61.78%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $0.78
Upside: +925.64%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $79.49
Upside: +22.03%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $12.21
Upside: +489.68%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $34.07
Upside: +222.86%
Mar 6, 2024
Maintains: Hold
Price Target: $0.5 → $1
Current: $0.93
Upside: +7.27%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $6.43
Upside: +444.32%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.87
Upside: +933.41%
Jan 11, 2022
Initiates: Buy
Price Target: $675
Current: $2.79
Upside: +24,093.55%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $4.19
Upside: +90.93%
Nov 12, 2021
Upgrades: Buy
Price Target: $3 → $4
Current: $0.29
Upside: +1,256.39%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $1.77
Upside: +1,086.44%